XML 123 R103.htm IDEA: XBRL DOCUMENT
v3.22.2.2

JOINT VENTURES AND ASSOCIATES - Investment in Joint Venture and affiliates (Details) - USD ($) | Jun. 30, 2022 | Jun. 30, 2021 | Jun. 30, 2020
--- | --- | --- | ---
JOINT VENTURES |  |  |
Investments in joint ventures and affiliates, Assets | $ 38,554,092 | $ 30,657,173 | $ 24,652,792
Investments in joint ventures and affiliates, Liabilities | 717,948 | 1,278,250 | 1,548,829
Synertech Industrias S.A. |  |  |
JOINT VENTURES |  |  |
Investments in joint ventures and affiliates, Assets | 35,646,740 | 27,572,597 | 24,619,773
Indrasa Biotecnologia S.A. |  |  |
JOINT VENTURES |  |  |
Investments in joint ventures and affiliates, Assets | 70,466 | 54,957 | 33,019
Alfalfa Technologies S.R.L. |  |  |
JOINT VENTURES |  |  |
Investments in joint ventures and affiliates, Assets | 74,827 | 97,920 |
Moolec Science Ltd |  |  |
JOINT VENTURES |  |  |
Investments in joint ventures and affiliates, Assets | 2,759,059 | 2,931,699 |
Moolec Science S.A. |  |  |
JOINT VENTURES |  |  |
Investments in joint ventures and affiliates, Assets | 3,000 |  |
Trigall Genetics S.A. |  |  |
JOINT VENTURES |  |  |
Investments in joint ventures and affiliates, Liabilities | $ 717,948 | $ 1,278,250 | $ 1,548,829

X
- Definition The non-current amount due to joint ventures and associates. + References No definition available. + Details
Name: | biox_DueToJointVenturesAndAssociatesNonCurrent
Namespace Prefix: | biox_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table. + References No definition available. + Details
Name: | ifrs-full_DisclosureOfJointVenturesLineItems
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The amount of investments in subsidiaries, joint ventures and associates in an entity's separate financial statements. [Refer: Associates [member]; Joint ventures [member]; Subsidiaries [member]; Investments in subsidiaries reported in separate financial statements] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 27 -IssueDate 2022-03-24 -Paragraph 10 -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2022-en-r&anchor=para_10&doctype=Standard -URIDate 2022-03-24 + Details
Name: | ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Details
Name: | ifrs-full_JointVenturesAxis=biox_SynertechIndustriasS.aMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_JointVenturesAxis=biox_IndrasaBiotecnologaS.a.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_JointVenturesAxis=biox_AlfalfaTechnologiesS.r.l.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_JointVenturesAxis=biox_MoolecScienceLimitedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_JointVenturesAxis=biox_MoolecScienceS.a.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_JointVenturesAxis=biox_TrigallGeneticsS.a.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |